Stay updated on Flotetuzumab in PIF/ER AML Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab in PIF/ER AML Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page was updated to show that recruitment is closed. It also adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading, while updating the revision banner to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-13T01:02:35.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5. This reflects an updated page revision in the site's versioning system rather than a change to study data or content.
    Difference
    0.0%
    Check dated 2026-06-05T23:49:46.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page now shows a newer revision version (v3.5.4) replacing the previous v3.5.3, indicating an update to the page version without altering the underlying study data.
    Difference
    0.0%
    Check dated 2026-05-15T14:22:43.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    This updates the ClinicalTrials.gov site’s displayed release/version from **v3.5.2** to **v3.5.3** without changing any study content.
    Difference
    0.0%
    Check dated 2026-04-24T06:18:02.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:38:43.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-19T06:30:54.000Z thumbnail image

Stay in the know with updates to Flotetuzumab in PIF/ER AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.